Jeffrey W. Albers - 26 Aug 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CEO and President, Director
Signature
/s/ Xing Yan, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
26 Aug 2021
Net transactions value
+$29,920
Form type
4
Filing time
30 Aug 2021, 16:04:01 UTC
Previous filing
23 Aug 2021
Next filing
03 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $29,920 +16,000 +9.3% $1.87* 188,448 26 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -16,000 -10% $0.000000 142,903 26 Aug 2021 Common Stock 16,000 $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 30, 2014 and is fully vested.